Meeting
2023 ASCO Annual Meeting
Healthcare utilization among individuals diagnosed with Lynch syndrome through a universal germline genetic testing program.
Authors
Heather Hampel
City of Hope, Duarte, CA
Heather Hampel , Ilana Solomon , Michael Garcia , Marilan Luong , Sarah Labib , Joseph D. Bonner , Lawrence Shaktah , Lauren Gima , Christine Hong , Gregory Idos , Sidney S. Lindsey , Kevin McDonnell , Wai Park , Katherine G. Roth , Elise Sobotka , Yi Xiao , Stanley R. Hamilton , Stephen B. Gruber , Stacy W. Gray
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Germline Genetic Testing
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 10603)
DOI
10.1200/JCO.2023.41.16_suppl.10603
Abstract #
10603
Poster Bd #
236
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
A pan-cancer statistical study of microsatellite instability and Lynch syndrome–associated mismatch repair genes germline mutations.
First Author: Huiya Cao
Poster
2018 ASCO Annual Meeting
Value of EGD for gastric cancer surveillance in patients with hereditary non-polyposis colorectal cancer (HNPCC) or Lynch syndrome (LS).
First Author: Swetlana Ladigan
Poster
2018 ASCO Annual Meeting
Clinical factors associated with urinary tract cancers (UTCs) among Lynch syndrome (LS) patients (Pts).
First Author: Jonathan W. Wischhusen
Poster
2018 Gastrointestinal Cancers Symposium
Contribution of Lynch syndrome to early onset malignancy in Ireland.
First Author: Alice Talbot